Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant

Eur J Hum Genet. 2021 Jul;29(7):1103-1109. doi: 10.1038/s41431-021-00825-w. Epub 2021 Feb 22.

Abstract

Hereditary Diffuse Gastric Cancer (HDGC) syndrome is associated with CDH1 germline likely pathogenic/pathogenic variants. Carriers of CDH1 germline likely pathogenic/pathogenic variants are predisposed to diffuse gastric cancer and lobular breast cancer. This study aims to classify the CDH1 c.[715G>A] missense variant identified in a diffuse gastric cancer prone family by performing splicing studies. RT-PCR and subsequent cloning experiments were performed to investigate whether this variant completely disrupts normal splicing. This variant preferentially abolishes normal splicing through activation of a cryptic 3' acceptor splice site within exon 6 of CDH1, presumably leading to a premature protein truncation within first extracellular domain repeat of E-cadherin protein. Our results contributed to evidence necessary to resolve pathogenicity classification of this variant, indicating that this variant is to be classified as pathogenic.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles*
  • Amino Acid Substitution*
  • Antigens, CD / genetics*
  • Biopsy
  • Cadherins / genetics*
  • Computational Biology / methods
  • DNA Mutational Analysis
  • Databases, Genetic
  • Female
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genotype*
  • Humans
  • Immunohistochemistry
  • Male
  • Mutation*
  • Pedigree
  • RNA Splice Sites
  • RNA Splicing
  • Stomach Neoplasms / diagnosis
  • Stomach Neoplasms / genetics

Substances

  • Antigens, CD
  • CDH1 protein, human
  • Cadherins
  • RNA Splice Sites